Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe

Assessments of clinical evidence vary between regulators and health technology assessment bodies, but precise differences remain unclear. To compare uncertainties raised on the clinical evidence of approved drugs, we analyzed assessments of regulators and health technology assessment (HTA) bodies in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Pharmacol Ther
Autors principals: Vreman, Rick A., Naci, Huseyin, Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G. M., Kesselheim, Aaron S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7484915/
https://ncbi.nlm.nih.gov/pubmed/32236959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1835
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars